Symposia
Dissemination & Implementation Science
Kristen Hagen, Ph.D. (he/him/his)
Norwegian University of Science and Technology
Trondheim, Sor-Trondelag, Norway
Bjarne Hansen, Ph.D. (he/him/his)
Professor
University of Bergen
Bergen, Hordaland, Norway
Throstur Bjorgvinsson, ABPP, Ph.D. (he/him/his)
McLean Hospital/Harvard Medical School
Waltham, Massachusetts, United States
Objective: This study evaluates the efficacy, feasibility, and patient satisfaction of the Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder (OCD), employing a concentrated cognitive-behavioral therapy approach, across various clinical settings in Norway.
Method: A cohort of 2000 consecutively referred OCD patients received the B4DT across over 20 specialized teams. OCD severity was assessed using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at pre-treatment, post-treatment, and at a 3-month follow-up. Secondary symptoms were evaluated using the Generalized Anxiety Disorder 7-item scale (GAD-7) for anxiety and the Patient Health Questionnaire (PHQ-9) for depression. Patient satisfaction was measured with the Client Satisfaction Questionnaire (CSQ-8). Treatment feasibility was gauged through completion rates and adherence to the protocol.
Results: Significant reductions in Y-BOCS scores were observed from pre-treatment to post-treat, underscoring its feasibility across different clinical settings.
Conclusion: The B4DT is an effective, feasible, and well-received treatment approach for OCD, significantly reducing symptoms of OCD, anxiety, and depression, with high levels of patient satisfaction across multiple clinical settings in Norway.